Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients.
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2015
At a glance
- Drugs Cisplatin; Gemcitabine
- Indications Cervical cancer
- Focus Therapeutic Use
- 06 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2009 New trial record